Association for the Advancement of Blood & Biotherapies

Association for the Advancement of Blood & Biotherapies
Name	Association for the Advancement of Blood & Biotherapies
Abbreviation	AABB
Formation	1947
Type	Professional association
Headquarters	Bethesda, Maryland
Region served	International
Membership	Blood banks, transfusion services, cellular therapies
Leader title	President

Association for the Advancement of Blood & Biotherapies is a nonprofit professional association focused on transfusion medicine, blood banking, cellular therapies, and biotherapies. Founded in the mid-20th century, it serves clinical laboratories, hospitals, research centers, regulatory bodies, and industry partners to promote safe and effective blood products and cellular therapies. The organization convenes conferences, publishes standards and scientific literature, and runs accreditation and proficiency programs that intersect with public health agencies, philanthropic foundations, and academic institutions.

History

The organization traces its origins to post-World War II initiatives in transfusion science, where collaboration among leaders from American Red Cross, National Institutes of Health, World Health Organization, and major university medical centers shaped early blood banking practices. During the 1950s and 1960s it engaged with investigators from Johns Hopkins University, Mayo Clinic, Massachusetts General Hospital, and Harvard Medical School to establish laboratory methods adopted in clinical practice. In later decades the association interacted with regulatory milestones involving Food and Drug Administration, Centers for Disease Control and Prevention, and international standards bodies such as International Society for Blood Transfusion and European Directorate for the Quality of Medicines & HealthCare. The organization evolved alongside developments in cellular therapy involving groups at National Cancer Institute, Fred Hutchinson Cancer Research Center, and biotechnology firms that later merged with multinational corporations like Pfizer, Novartis, and Roche. Key historical events include responses to emerging infectious risks such as HIV/AIDS and Zika virus outbreaks, and adaptation to technological advances exemplified at meetings with stakeholders from American Society of Hematology and American Association of Blood Banks.

Mission and Objectives

The association's stated mission centers on improving patient and donor outcomes by advancing practice, science, and standards for blood and cellular products in collaboration with organizations such as World Health Organization, Pan American Health Organization, and national health ministries. Objectives include developing evidence-based standards in coordination with academic partners like Stanford University School of Medicine, supporting workforce development through partnerships with professional societies including American Society for Clinical Pathology and Society for Immunotherapy of Cancer, and fostering research alliances with institutes like Scripps Research and Cold Spring Harbor Laboratory. The organization emphasizes alignment with regulatory frameworks established by European Medicines Agency, Health Canada, and regional public health authorities.

Membership and Governance

Membership comprises institutional entities—hospital transfusion services, regional blood centers, academic laboratories—and individual professionals such as physicians, technologists, and researchers affiliated with institutions like Cleveland Clinic, UCSF Medical Center, University of Pennsylvania Health System, and Karolinska Institutet. Governance is overseen by an elected Board of Directors drawing on leaders from entities including American Medical Association, Association of American Medical Colleges, and philanthropic organizations like Bill & Melinda Gates Foundation. Committees and task forces include representation from regulatory liaisons with Food and Drug Administration and international advisors from European Blood Alliance and Japan Red Cross Society. Credentialing programs are administered by volunteer experts and staff operating under bylaws modeled on nonprofit governance used by The Joint Commission and major professional associations.

Conferences and Educational Programs

The organization hosts annual scientific meetings and specialized courses that attract clinicians and scientists associated with American Society of Hematology, International Society for Cellular Therapy, and researchers from institutions such as University of Oxford and Karolinska Institutet. Educational programs include workshops on blood component therapy, apheresis, and cellular therapy manufacturing developed with instructors from Mayo Clinic and Memorial Sloan Kettering Cancer Center, and continuing education credits recognized by professional boards including American Board of Pathology. The meetings feature plenary sessions with speakers from regulatory agencies like Food and Drug Administration and global public health agencies, poster presentations from investigators at universities such as University of Toronto and Monash University, and exhibitors from biotech companies including Thermo Fisher Scientific and GE Healthcare.

Research and Publications

The association publishes peer-reviewed guidance, practice bulletins, and a scientific journal that disseminate research by investigators from centers like Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, and Toronto General Hospital. Its publications cover immunohematology, transfusion-transmitted infection surveillance in collaboration with Centers for Disease Control and Prevention, and clinical outcomes research involving collaborators from Brigham and Women's Hospital and University College London. The organization sponsors multicenter studies and registries that align with data initiatives from National Institutes of Health, European Blood and Marrow Transplant Group, and disease-specific consortia such as CIBMTR.

Standards, Accreditation, and Advocacy

The association develops standards and runs accreditation programs adopted by blood centers and hospital transfusion services, interfacing with accreditation models from The Joint Commission and regulations enforced by Food and Drug Administration and Health Canada. Standards address quality management, donor eligibility, molecular testing, and manufacturing of cellular therapies consistent with good manufacturing practice frameworks promoted by European Medicines Agency and national health authorities. Advocacy efforts engage lawmakers and policy-makers in legislatures such as the United States Congress and agencies involved in pandemic preparedness, working with coalitions that include American Hospital Association and Infectious Diseases Society of America.

Awards and Recognition

The organization confers awards and honors recognizing scientific achievement, clinical innovation, and lifetime service, often awarded to professionals affiliated with institutions like Johns Hopkins Hospital, Mayo Clinic, and Children's Hospital of Philadelphia. Award recipients frequently include researchers whose work appears in journals alongside those from Nature Medicine, The Lancet, and New England Journal of Medicine, and leaders who have shaped policy in collaboration with agencies such as World Health Organization and Centers for Disease Control and Prevention.

Category:Medical associations Category:Blood donation Category:Transfusion medicine